|
|
|
Insider
Information: |
Halak Brian K |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
28 |
|
Direct
Shares |
10,552,431 |
|
Indirect Shares
|
959,812 |
|
|
Direct
Value |
$74,926,074 |
|
|
Indirect Value
|
$10,163,779 |
|
|
Total
Shares |
11,512,243 |
|
|
Total
Value |
$85,089,852 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Northstar Neuroscience Inc |
NSTR |
Director |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
3,415 |
2008-04-24 |
56,718 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
4,529 |
2011-12-22 |
50,643 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2006-05-09 |
100,355 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2010-03-26 |
7,276 |
2010-03-26 |
0 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
2014-11-17 |
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2015-03-20 |
2,216,935 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
55,296 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-21 |
17,171 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
2016-05-26 |
606,283 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2014-09-10 |
2,763,294 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
25,730 |
2018-11-06 |
19,150 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Otonomy, Inc. |
OTIC |
10% Owner |
2014-08-18 |
11,715 |
2014-08-18 |
0 |
Premium* |
|
Atara Biotherapeutics, Inc. |
ATRA |
10% Owner |
2014-10-21 |
15,890 |
2014-10-21 |
0 |
Premium* |
|
Evofem Biosciences Inc |
EVFM |
10% Owner |
2014-11-25 |
3,091,643 |
2014-11-25 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
10% Owner |
2015-05-12 |
13,414 |
2015-05-12 |
0 |
Premium* |
|
Glaukos Corp |
GKOS |
10% Owner |
2015-06-30 |
6,501 |
2015-06-30 |
0 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
Director |
2021-09-17 |
327 |
2015-07-16 |
0 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
10% Owner |
2016-03-08 |
5,641 |
2016-03-08 |
0 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2019-08-06 |
813,433 |
2016-10-12 |
0 |
Premium* |
|
Bionano Genomics, Inc |
BNGO |
10% Owner |
2018-08-23 |
943,878 |
2018-08-23 |
0 |
Premium* |
|
Alliqua BioMedical Inc |
ALQA |
10% Owner |
2019-05-03 |
22,527 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-20 |
4 |
B |
$6.93 |
$1,732,500 |
I/I |
250,000 |
37,090 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-23 |
4 |
B |
$6.93 |
$1,039,500 |
I/I |
150,000 |
39,606 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-24 |
4 |
B |
$6.75 |
$337,500 |
I/I |
50,000 |
40,445 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-17 |
4 |
B |
$7.55 |
$755,000 |
I/I |
100,000 |
42,122 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-18 |
4 |
B |
$7.50 |
$285,750 |
I/I |
38,100 |
42,761 |
1.5 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
B |
$4.00 |
$9,399,996 |
I/I |
2,349,999 |
110,555 |
1.5 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
169,251 |
1.5 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2011-11-21 |
4 |
B |
$13.00 |
$12,111,879 |
I/I |
931,683 |
51,013 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2011-12-22 |
4 |
B |
$1.45 |
$680,263 |
I/I |
469,147 |
50,643 |
1.5 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
10% Owner |
|
2012-07-24 |
4 |
B |
$9.00 |
$7,058,817 |
I/I |
784,313 |
22,306 |
1.5 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
B |
$14.00 |
$3,999,996 |
I/I |
285,714 |
35,253 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
4/A |
B |
$6.03 |
$5,999,992 |
I/I |
995,618 |
7,333 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
4 |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,897,336 |
1.5 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
10% Owner |
|
2014-10-21 |
4 |
B |
$11.00 |
$20,251 |
D/D |
1,841 |
15,890 |
2.37 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2014-10-21 |
4 |
B |
$20.00 |
$10,000,000 |
D/D |
500,000 |
2,566,935 |
2.45 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
10% Owner |
|
2014-10-21 |
4 |
B |
$11.00 |
$2,729,749 |
D/D |
248,159 |
2,141,542 |
2.45 |
- |
|
EVFM |
Evofem Biosciences Inc |
10% Owner |
|
2014-11-25 |
4/A |
B |
$14.00 |
$980,000 |
D/D |
70,000 |
3,091,643 |
2.45 |
- |
|
EVFM |
Evofem Biosciences Inc |
10% Owner |
|
2014-11-25 |
4 |
B |
$14.00 |
$980,000 |
D/D |
70,000 |
3,091,642 |
2.45 |
- |
|
TBRA |
Tobira Therapeutics Inc |
10% Owner |
|
2015-05-04 |
4 |
B |
$10.62 |
$2,949,992 |
D/D |
277,777 |
3,553,322 |
2.45 |
- |
|
BNGO |
Bionano Genomics, Inc |
10% Owner |
|
2018-08-23 |
4 |
B |
$6.13 |
$91,875 |
D/D |
15,000 |
943,878 |
2.45 |
- |
|
RSLS |
ReShape Lifesciences Inc |
10% Owner |
|
2018-08-23 |
4 |
B |
$1.82 |
$3,000,013 |
D/D |
1,648,359 |
5,634,329 |
2.45 |
- |
|
RSLS |
ReShape Lifesciences Inc |
10% Owner |
|
2019-08-06 |
4 |
B |
$4.00 |
$1,000,000 |
D/D |
250,000 |
813,433 |
2.45 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2012-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,200,000) |
6,772,968 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-01-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000,000) |
5,772,968 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2014-03-19 |
4 |
D |
$14.00 |
$42,712,894 |
I/I |
(3,050,921) |
0 |
0 |
- |
|
152 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|